高能聚焦超声刀联合氟脲嘧啶、四氢叶酸治疗晚期胰腺癌临床疗效观察

目的探讨高能聚焦超声刀加氟脲嘧啶、四氢叶酸治疗晚期胰腺癌临床疗效及毒副作用。方法30例经病理学或细胞学确诊的晚期胰腺癌病人先用高能聚焦超声刀(HIFU)治疗，再予氟脲嘧啶、四氢叶酸联合化疗。氟脲嘧啶500mg／m^2加入5％GNS500ml静滴持续6小时以每天1次连用5天，CF(四氢叶酸)100mg／m^2加入生理盐水250ml静滴每天1次连用5天，28天为1周期，至少治疗2个周期。结果CR1例；PR9例；MR9例；NC5例；PD6例。总有效率63％。毒副作用主要消化道反应，其他副作用轻微。结论应用HIFU局部治疗胰腺癌同时合用四氢叶酸加氟脲嘧啶全身化疗近期疗效提高明显，止痛明显达75％，副反应小，值得应用。     

旁正中动脉入口部梗死82例临床分析

目的探讨急性桥脑旁正中动脉入口部梗死(branch atheromatous disease,BAD)的临床特点。方法回顾性分析1997～2003年本院神经内科收治的82例桥脑BAD的临床表现、MRI影像特点、脑干听觉诱发电位(BAEP)表现、危险因素。结果本组病例的临床特点是:平均发病年龄69.2岁,男性/女性=46/36,56/82病情呈进行性发展,75/82有构音障碍,72/82有肢体偏瘫,29/82为高度肢体瘫痪,27/82有轻度意识障碍,6/82伴有不全Homer征,49/82出现面部或(和)偏侧肢体感觉减退,25/82出现周围性面瘫,42/82有非旋转性头晕;13/82有眼球运动障碍。MRI表现有:梗死灶位于桥脑中上部、达桥脑表面,楔形,内侧位于桥脑旁正中、呈类似直线,可显示出基底动脉壁不整;危险因素方面除高血压外还与糖尿病、脂质代谢异常有关。结论根据临床特点及MRI表现正确诊断出桥脑BAD,以指导进一步的病因治疗及预防。     

骨质疏松动物实验骨折风险性分析

目的:评价骨质疏松动物模型发生骨折的风险性.方法:健康雌性SD大鼠36只,随机分为实验组和对照组各18只.实验组切除双侧卵巢,对照组仅切开皮肤.于术后2、4、8周两组处死6只大鼠,作松质骨(腰椎)和皮质骨(股骨干)骨密度(BMD)组织形态学和力学测定.结果:与对照组相比,手术组松质骨BMD 2、4、8周均明显下降,2周皮质骨无明显差异,4、8周则明显下降;股骨中段骨皮质厚度变薄;骨小梁体积(TBV)占全部骨组织体积(TTV)的百分比明显减少;成骨细胞和破骨细胞明显增多;股骨最大弯曲载荷、腰椎最大压缩载荷下降.     

小鼠牙髓干细胞培养及诱导分化

目的 :分离、培养小鼠牙髓干细胞并诱导分化 .方法 :采用酶消化培养法获得小鼠的单个牙髓细胞悬液 ,细胞密度调整为 1× 10 4/孔细胞 ,用 2 0 0mL·L -1胎牛血清的α MEM培养液培养 14d ,挑出细胞克隆消化传代 ,TGF β、BMP2 、bFGF细胞因子诱导 ,PCR检测DSPP的mRNA的表达 .结果 :小鼠牙髓细胞呈集落状生长 ,克隆形成率为 1.6 -2 .5个 / 10 4细胞 ,所形成的集落细胞结合紧密 ,细胞体积小、胞核大 ,经细胞因子刺激后的细胞表达DSPP的mRNA .结论 :培养的小鼠牙髓集落状生长的细胞具有干细胞增殖快等特性 ,细胞因子可诱导小鼠牙髓干细胞定向分化     

噪声中EP信号的提取算法及研究进展

诱发电位的提取是脑电信号处理领域的前沿课题近年来 ,通过少次甚至单次试验提取诱发电位已经成为研究的主流。本文对近年来提取诱发电位的信号处理方法进行了简要的回顾 ,并分别从小波变换、神经网络、高阶累积量、独立分量分析等四个方面对算法进行了介绍     

结缔组织生长因子在脑胶质瘤组织中的表达和肿瘤级别的关系

目的通过检测人脑胶质瘤患者肿瘤组织中结缔组织生长因子的表达水平,探讨其和肿瘤级别的关系及作用机制。方法采用荧光实时定量聚合酶链式反应(RT-PCR)法检测结缔组织生长因子(CTGF)mRNA在47例脑胶质瘤组织和25例正常脑组织中的表达水平,统计分析表达水平和肿瘤级别之间的关系。结果CTGF在胶质瘤Ⅰ-Ⅱ级(高分化组)及胶质瘤Ⅲ~Ⅳ级(低分化组)中的表达均明显高于正常脑组织(P<0.01),而且在Ⅲ~Ⅳ级胶质瘤中的表达量显著高于胶质瘤Ⅰ~Ⅱ级(P<0.01),说明随着肿瘤级别的升高CTGF表达也增强。结论CTGF在胶质瘤组织中高表达,而且表达水平和恶性程度有密切联系。CTGF的检测可作为胶质瘤恶性程度判断的参考,为从基因水平上探讨胶质瘤的生物学行为、预后及治疗提供新的思路。     

Functional differences among those high and low on a trait measure of psychopathy.

BACKGROUND: It has been established that individuals who score high on measures of psychopathy demonstrate difficulty when performing tasks requiring the interpretation of other's emotional states. The aim of this study was to elucidate the relation of emotion and cognition to individual differences on a standard psychopathy personality inventory (PPI) among a nonpsychiatric population. METHODS: Twenty participants completed the PPI. Following survey completion, a mean split of their scores on the emotional-interpersonal factor was performed, and participants were placed into a high or low group. Functional magnetic resonance imaging data were collected while participants performed a recognition task that required attention be given to either the affect or identity of target stimuli. RESULTS: No significant behavioral differences were found. In response to the affect recognition task, significant differences between high- and low-scoring subjects were observed in several subregions of the frontal cortex, as well as the amygdala. No significant differences were found between the groups in response to the identity recognition condition. CONCLUSIONS: Results indicate that participants scoring high on the PPI, although not behaviorally distinct, demonstrate a significantly different pattern of neural activity (as measured by blood oxygen level-dependent contrast)in response to tasks that require affective processing. The results suggest a unique neural signature associated with personality differences in a nonpsychiatric population.     

Effects of weight loss in overweight/obese individuals and long-term lipid outcomes – a systematic review

This paper aims to review the evidence for long‐term effectiveness of weight loss on cholesterol, high‐density lipoprotein (HDL), low‐density lipoprotein (LDL) and triglycerides in overweight/obese people. Current evidence is mostly based on short‐term studies. A systematic review of long‐term lipid outcomes of weight loss in studies published between 1966 and 2001, was conducted. Inclusion criteria included all cohort studies and trials carried out on participants with body mass index of greater than or equal to 28 kg m^?2. Studies had at least two weight change measurements and follow‐up of more than 2 years. Thirteen long‐term studies with a follow‐up of more than 2 years were included. Cholesterol has a significant positive linear relationship with weight change (r = 0.89) where change in weight explains about 80% of the cholesterol difference variation (Adj R² = 0.80). For every 10 kg weight loss a drop of 0.23 mmol L^?1 in cholesterol may be expected for a person suffering from obesity or are grossly overweight. Weight loss has long‐term beneficial effects especially on LDL and cholesterol. Weight loss in obese patients should be encouraged and sustained.     

抗抑郁剂对慢性应激抑郁大鼠脑内5-HT1A受体和5-HT2A受体的影响

目的 以慢性不可预见性应激抑郁模型为基础,探讨三环类抗抑郁剂 (TCAs)和 5 羟色胺再摄取抑制剂(SSRI)在 5 羟色胺受体水平的药理学机理。方法 将 24只SD雄性大鼠随机分对照组、抑郁模型组、阿米替林治疗组、氟西汀治疗组。应用 [3H]8 OH DPAT、[3H]Ketanserin作为标记配基,采用放射性配体受体结合法,分别测定大鼠海马 5 HT1A受体、大脑皮层 5 HT2A受体的特异性结合。结果 与正常对照组比较,抑郁大鼠海马 [3H] 8 OH DPAT特异性结合明显下降 ( 18. 78±5. 62vs26. 12±5. 52, P<0. 05),抑郁大鼠大脑皮层[3H]Ketanserin特异性结合显著增加(86. 28±4. 24vs112. 58±4. 21,P<0. 05)。阿米替林治疗 3周后,抑郁大鼠海马 [3H] 8 OH DPAT特异性结合回升到正常水平,大脑皮层 [3H]Ketan serin特异性结合下降至正常水平(P<0. 05)。氟西汀治疗 3周后,抑郁大鼠海马 [3H]8 OH DPAT特异性结合(26. 63±5. 50)、大脑皮层[3H]Ketanserin特异性结合 (83. 16±2. 54)与抑郁组比较差异无显著性 (P>0. 05)。结论 1.阿米替林通过增强海马 5 HT1A受体功能、抑制大脑皮层 5 HT2A受体功能发挥抗抑郁作用。2.氟西汀可能不通过影响海马 5 HT1A受体和大脑皮层 5 HT2A受体功能发挥抗抑郁作用。